Patent Baristas

Academics at Cambridge University are divided over a new proposal by the university to tighten its control over intellectual property created by faculty by managing patent applications and taking a stake in spin-out companies. Under the current regulations, the university has no effective control over intellectual property created by the majority of its staff. The […]

The Intellectual Property Department of Frost Brown Todd LLC has beefed up its trademark and copyright practice Jones Day attorney Joseph Dreitler has joined the firm as Chair of the Trademark & Copyright Practice Group, along with his colleagues Mary True and Brian Downey. Dreitler’s group has represented top clients such as Elizabeth Arden, K-Mart, […]

While we’re on the subject of patent re-exam lately, I received a letter from a plucky individual that has decided to file a request for ex parte reexamination of Amazon’s “One-Click” patent (US Patent 5,960,411), using some prior art that he found. It turns out that New Zealander Peter Calveley is one of the actors […]

The title to the Public Patent Foundation (“PUBPAT”) news release said it all: “PUBPAT Receives Substantial Victory in Lipitor Patent Challenge: Pfizer Concedes to Give Up Original Broad Patent Claims. Or, does it? PUBPAT touted that in the challenge it filed last year against Pfizer Inc.’s patent on Lipitor, “Pfizer has conceded to significantly narrow […]

A US Court of Appeals for the Federal Circuit (CAFC) upheld a ruling which blocked sales of Ranbaxy’s generic alternative to Pfizer Inc’s Accupril blood pressure drug (Quinapril HCl), a generic equivalent of Pfizer’s (Parke Davis) anti-hypertensive agent Accupril Tablets. [Pfizer, Inc. and Warner-Lambert Company, LLC, v. Teva Pharmaceuticals USA, Inc., Ranbaxy Pharmaceuticals, Inc., and […]